Evidence map›Paper›PMID 37081677›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Reply to the Letter "Reversible Vasoconstriction Syndrome Is a Complication of SARS-CoV-2 Infection/Vaccination Rather than That of Leigh Syndrome".

Ayane Ohyama-Tamagake, Kimihiko Kaneko, Ryo Itami, Masatsugu Nakano, Yasuhiro Namioka, Rumiko Izumi, Haruka Sato, Hideaki Suzuki, Atsuhito Takeda, Yukiko Yatsuka and 6 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Ayane Ohyama-TamagakeDepartments of Neurology, Tohoku University Hospital, Japan.
Kimihiko KanekoDepartments of Neurology, Tohoku University Hospital, Japan.
Ryo ItamiDepartment of Neurology, Tokyo General Hospital, Japan.
Masatsugu NakanoDepartment of Cardiology, Tokyo General Hospital, Japan.
Yasuhiro NamiokaDepartments of Neurology, Tohoku University Hospital, Japan.
Rumiko IzumiDepartments of Neurology, Tohoku University Hospital, Japan.
Haruka SatoDepartment of Cardiology, Tohoku University Hospital, Japan.
Hideaki SuzukiDepartment of Cardiology, Tohoku University Hospital, Japan.
Atsuhito TakedaDepartment of Pediatrics, Hokkaido University Hospital, Japan.
Yukiko YatsukaDiagnostics and Therapeutic of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Japan.
Yasushi OkazakiDiagnostics and Therapeutic of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Japan.
Takaaki AbeDepartment of Clinical Biology and Hormonal Regulation, Tohoku University Hospital, Japan.
Kei MurayamaDepartment of Metabolism, Chiba Children's Hospital, Japan.
Naoto SugenoDepartments of Neurology, Tohoku University Hospital, Japan.
Tatsuro MisuDepartments of Neurology, Tohoku University Hospital, Japan.
Masashi AokiDepartments of Neurology, Tohoku University Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Leigh DiseaseHumansSARS-CoV-2SyndromeVaccinationVasoconstrictionLeigh syndromeReversible vasoconstriction syndrome

Identifiers

PMID37081677
PMCPMC10400391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.